Weinstein Y, Ran S, Segal S
J Immunol. 1984 Feb;132(2):656-61.
The immunologic potential of T lymphocytes and antigen-presenting cells (APC) from male and female mice were compared. Lymphocytes from female mice or from male mice that cannot produce and respond to testosterone (Tfm/y) were more reactive than male lymphocytes to alloantigens in MLR. Spleen cells from Tfm/y mice equipped with estrogen implants showed a higher responsiveness than control Tfm/y to alloantigens. The removal of suppressive adherent cells or the addition of T cell growth factor (TCGF) enhanced the proliferative activity of the cells in the MLR. The responsiveness of female cells to alloantigens, however, remained superior to that observed in male cells. Similarly, in the presence of TCGF, thymocytes from female mice react more effectively than male cells in MLR. In addition, Con A-stimulated spleen cells from female mice produce more interleukin 2 (IL 2) than do spleen cells from males or female mice treated with testosterone. Lymphocytes from immunized mice were tested for their ability to respond to soluble antigens (KLH and OVA) in vitro. Again, female immunocompetent cells respond more vigorously than male cells or cells originating in female mice with testosterone implants. APC from female spleen were more efficient than male APC in initiating a secondary response in primed lymphocytes from either males or female mice. Moreover, castration of male mice enhanced, and treatment of female mice with androgen reduced, the efficiency of antigen presentation. In conclusion, these data suggest that female cells are superior to male cells in immunologic functions that are known to be associated with reactions to and recognition of histocompatibility antigens, i.e., antigen presentation and MLR. Furthermore, our present data indicate that the differential reactivity of immunocytes between male and female mice depends on the hormonal balance of the animal.
比较了雄性和雌性小鼠的T淋巴细胞及抗原呈递细胞(APC)的免疫潜能。来自雌性小鼠或不能产生及应答睾酮的雄性小鼠(Tfm/y)的淋巴细胞,在混合淋巴细胞反应(MLR)中对同种异体抗原的反应性比雄性淋巴细胞更强。植入雌激素的Tfm/y小鼠的脾细胞对同种异体抗原的反应性高于对照Tfm/y小鼠。去除抑制性贴壁细胞或添加T细胞生长因子(TCGF)可增强细胞在MLR中的增殖活性。然而,雌性细胞对同种异体抗原的反应性仍优于雄性细胞。同样,在存在TCGF的情况下,雌性小鼠的胸腺细胞在MLR中的反应比雄性细胞更有效。此外,与雄性小鼠或经睾酮处理的雌性小鼠的脾细胞相比,雌性小鼠经刀豆蛋白A刺激的脾细胞产生更多的白细胞介素2(IL-2)。检测了免疫小鼠的淋巴细胞在体外对可溶性抗原(钥孔血蓝蛋白和卵清蛋白)的反应能力。同样,具有免疫活性的雌性细胞比雄性细胞或来自植入睾酮的雌性小鼠的细胞反应更强烈。来自雌性脾脏的APC在引发雄性或雌性小鼠致敏淋巴细胞的二次反应方面比雄性APC更有效。此外,雄性小鼠去势可增强抗原呈递效率,而用雄激素处理雌性小鼠则降低抗原呈递效率。总之,这些数据表明,在已知与组织相容性抗原的反应和识别相关的免疫功能,即抗原呈递和MLR方面,雌性细胞优于雄性细胞。此外,我们目前的数据表明,雄性和雌性小鼠免疫细胞的反应性差异取决于动物的激素平衡。